Merck is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available as an Ebola treatment to address the widening outbreak in the Democratic Republic of Congo, a senior executive told Reuters. The outbreak, which has so far infected a suspected 1,100 people and resulted in 42 deaths, involves a rare strain of the virus called Bundibugyo…
